Yashfin Pharmaceuticals Private Limited
About Yashfin Pharmaceuticals Private Limited
Data last updated:
Yashfin Pharmaceuticals Private Limited is a private limited company based in Nagda, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24100MP2016PTC041161. Its GSTIN is 23AAACY8200F1ZQ (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ahmed Noor and Haroon Rashid Mansuri.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 63 Janmejay Marg, Nagda, Madhya Pradesh, India – 456335.
As per the financials filed for FY 2021, the company reported a revenue of ₹18.17 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹27,259 (net margin 1.5%) and EBITDA of ₹43,833 (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 85% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Yashfin Pharmaceuticals Private Limited's registered office is in Nagda, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address63 Janmejay Marg, Nagda, Madhya Pradesh, India – 456335
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Yashfin Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Yashfin Pharmaceuticals is information and communication. In detail, this covers publishing of computer operating systems, system software, application software, games, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J2 | Publishing of computer operating systems, system software, application software, games, etc. |
To see the full business activity and turnover split of Yashfin Pharmaceuticals Private Limited, buy the company report.
Financials of Yashfin Pharmaceuticals Private Limited
FY 2021 filings availableYashfin Pharmaceuticals Private Limited reported revenue of ₹18.17 Lakh (up 158% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 85% over three years, including 158% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹43,833 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹27,259 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Yashfin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Yashfin Pharmaceuticals Private Limited
Yashfin Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ahmed Noor | Director | 18 Jul 2016 | 10 Years 3 Months | Current |
| Haroon Rashid Mansuri | Director | 18 Jul 2016 | 10 Years 3 Months | Current |
Auditor
Yashfin Pharmaceuticals Private Limited is audited by J S S & COMPANY for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J S S & COMPANY | FY 2019 | 013580C |
Shareholding
The shareholding of Yashfin Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Yashfin Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Yashfin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Yashfin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Yashfin Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACY8200F1ZQ | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Yashfin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Yashfin Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Ahmed Noor was appointed as Director on 18 Jul 2016.
Frequently asked questions
Yashfin Pharmaceuticals is an active private limited company based in Nagda, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 July 2016 (10+ years old) and is registered under CIN U24100MP2016PTC041161.
Yashfin Pharmaceuticals has 2 current directors:
- Ahmed Noor - Director
- Haroon Rashid Mansuri - Director
The latest financial statements of Yashfin Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Yashfin Pharmaceuticals is 23AAACY8200F1ZQ, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Yashfin Pharmaceuticals is U24100MP2016PTC041161. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yashfin Pharmaceuticals was incorporated on 18 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.
Ahmed Noor was appointed as Director on 18 Jul 2016. Haroon Rashid Mansuri was appointed as Director on 18 Jul 2016.
The registered office of Yashfin Pharmaceuticals is at 63 Janmejay Marg, Nagda, Madhya Pradesh, India – 456335.
Yashfin Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Yashfin Pharmaceuticals is compliant as of 06 August 2026. The company is actively filing with the Registrar of Companies.